mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.01 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.01 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.01 |
mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
0.091 |
0.01 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.01 |
mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.01 |
mRNA |
AZD7762 |
GDSC1000 |
pan-cancer |
AAC |
-0.084 |
0.01 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.01 |